Osteonecrosis of the jaw associated with bevacizumab in treatment: A case series using the FDA Adverse Event Reporting System (FAERS) database

Authors

Hardeep S. Ahdi, Advocate Aurora HealthFollow
Thomas A. Wichelmann, Advocate Aurora HealthFollow
Sasirekha Pandravada, Advocate Aurora HealthFollow
Eli Ehrenpreis, Advocate Aurora HealthFollow

Recommended Citation

Ahdi H, Wichelmann T, Pandravada S, Ehrenpreis E. S166 Osteonecrosis of the Jaw Associated With Bevacizumab in Treatment: A Case Series Using the FDA Adverse Event Reporting System (FAERS) Database. The American Journal of Gastroenterology. 2022; 117 (10S): e119-e119. doi: 10.14309/01.ajg.0000857304.82748.c1.

Affiliations

Advocate Lutheran General Hospital

Type

Abstract